Govt notifies scheme for `Promotion of Medical Device Parks'
27 September 2021
A total of 16 state governments and union territories, including Himachal Pradesh, Tamil Nadu, Madhya Pradesh and Uttar Pradesh, have given “in-principle” approval for setting up Medical Device Parks under the scheme for `Promotion of Medical Device Parks.’
The total financial outlay of the scheme is Rs400 crore and the tenure of the scheme is from FY 2020-2021 to FY 2024-2025. The financial assistance to a selected medical device park would be 70 per cent of the project cost of common infrastructure facilities. In case of North Eastern states and hilly states, financial assistance would be 90 per cent of the project cost. Maximum assistance under the scheme for one medical device park would be limited to Rs100 crore.
The selection of the states/UTs is based on the challenge method, which is reflected in the evaluation criteria of the scheme. The ranking methodology for states/UTs is based on the parameters prescribed in the scheme guidelines such as utility charges, state policy incentives, total area of the park, land lease rate, connectivity of the park, ease of doing business ranking, availability of technical manpower etc. Based on the evaluation, the proposals of state government of Himachal Pradesh, Tamil Nadu, Madhya Pradesh and Uttar Pradesh have been given “in-principle” approval under the scheme. Further qualitative assessment of these states in terms of their fiscal capability, ecosystem attractiveness and industrial presence also validated the selection.
Government of India has taken a key initiative to support the medical devices industry to reach its potential in the coming years, identifying the industry is as a sunrise sector with great potential for diversification and employment generation.
Recognising the need for higher levels of investments for the creation of proper infrastructure in the sector, the Department of Pharmaceuticals has notified the scheme for `Promotion of Medical Device Parks’ with the objectives of easy access to standard testing and infrastructure facilities and reaping the benefits arising from optimisation of resources and economies of scale.
The creation of world class common infrastructure facilities and increased competitiveness will result in significant reduction of the cost of production of medical devices, leading to better availability and affordability of medical devices in the domestic market, the ministry of chemicals and fertilisers stated in a release
Medical Devices Parks, to be developed under the scheme, will provide common infrastructure facilities at one place thereby creating a robust ecosystem for the medical device manufacturing in the country and also reducing the manufacturing cost significantly.